Using an intrauterine device in immunocompromised women
Browne, H.; Manipalviratn, S.; Armstrong, A.
Obstetrics and Gynecology 112(3): 667-669
2008
ISSN/ISBN: 0029-7844 PMID: 18757667 DOI: 10.1097/aog.0b013e318183464eDocument Number: 203097
Intrauterine devices (IUDs) are a viable treatment option for immunocompromised women who need contraception or menses suppression. They may also be an alternative treatment for women who have a contraindication to estrogen use. A review of the literature on IUD use in this population is sparse, but currently available data suggest that immunocompromised women are not at greater risk of developing pelvic infections.
Document emailed within 0-6 h
Related Documents
Archer, D.F.; Desoto, K.R.; Baker, J.M. 1999: Interleukin-6 and tumor necrosis factor-α concentrations in the intrauterine cavity of postmenopausal women using an intrauterine delivery system releasing progesterone : A possible mechanism of action of the intrauterine device Contraception (Stoneham) 59(3): 175-179Archer, D.F.; DeSoto, K.R.; Baker, J.M. 1999: Interleukin-6 and tumor necrosis factor-alpha concentrations in the intrauterine cavity of postmenopausal women using an intrauterine delivery system releasing progesterone. a possible mechanism of action of the intrauterine device Contraception 59(3): 175-179
Munteanu, O.; Cirstoiu, M.; Antoniac, I.; Cirstoiu, C. 2016: Comparison of Pain Level During and After Intrauterine Device Insertion: Levonorgestrel-Releasing Intrauterine System Versus the Copper T Intrauterine Device Environmental Engineering and Management Journal 15(5): 965-972
Akintomide, H.; James, A.; Moffat, M.; Barnes, P.; Rankin, J. 2022: Systematic review of copper intrauterine contraception continuation in young nulliparous women based on intrauterine device type Bmj Open 12(10): E060606
Akintomide, H.; James, A.; Moffat, M.; Barnes, P.; Rankin, J. 2022: Systematic review of copper intrauterine contraception continuation in young nulliparous women based on intrauterine device type Bmj Open 12(10): E060606
Andolsek, L.; Teeter, R.A.; Kozuh Novak, M.; Wheeler, R.; Fortney, J.A.; Rosenberg, M.J. 1986: Time to conception after intrauterine device removal importance of duration of use intrauterine device type pelvic inflammatory disease and age International Journal of Gynecology and Obstetrics 24(3): 217-224
Brunie, A.él.; Stankevitz, K.; Nwala, A.A.; Nqumayo, M.; Chen, M.; Danna, K.; Afolabi, K.; Rademacher, K.H. 2021: Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia LANCET. Global Health 9(10): E1431-E1441
Brunie, A.él.; Stankevitz, K.; Nwala, A.A.; Nqumayo, M.; Chen, M.; Danna, K.; Afolabi, K.; Rademacher, K.H. 2021: Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia LANCET. Global Health 9(10): E1431-E1441
Brunie, A.él.; Stankevitz, K.; Nwala, A.A.; Nqumayo, M.; Chen, M.; Danna, K.; Afolabi, K.; Rademacher, K.H. 2021: Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia LANCET. Global Health 9(10): E1431-E1441
Ozgu-Erdinc, A.S.; Tasdemir, U.G.; Uygur, D.; Aktulay, A.; Tasdemir, N.; Gulerman, H.C. 2014: Outcome of intrauterine pregnancies with intrauterine device in place and effects of device location on prognosis Contraception 89(5): 426-430
Blumenthal, P.D.; Goldthwaite, L.M. 2015: Intrauterine Device Insertion During Cesarean Delivery: the Rising Tide of the Postdelivery Intrauterine Device Obstetrics and Gynecology 126(1): 1-2
Roy, S.; Azen, C. 1994: A reanalysis of the Cu-7 intrauterine contraceptive device clinical trial and the incidence of pelvic inflammatory disease: A paradigm for assessing intrauterine contraceptive device safety American Journal of Obstetrics and Gynecology 170(6): 1606
Wang, K.; Cheng, Y.; Yang, H.; Tang, Y.H.; Jiang, J.; Ji, F.; Li, L.B.; Wu, S.C. 2016: Effectiveness research of medicated γ intrauterine device and medicated genefix intrauterine device inserted immediately after abortion Zhonghua Fu Chan Ke Za Zhi 51(3): 198-203
Bignardi, G.E. 1988: Candidiasis in women fitted with an intrauterine contraceptive device British Journal of Obstetrics and Gynaecology 95(10): 1083-1084
Haukkamaa, M.; Stranden, P.; Jousimies-Somer, H.; Siitonen, A. 1987: Bacterial flora of the cervix in women using an intrauterine device Contraception 36(5): 527-534
Bignardi, G.E. 1988: Candidiasis in women fitted with an intrauterine contraceptive device British Journal of Obstetrics and Gynaecology 95(10): 1083-1084
Agostini, A.; Crochet, P.; Petrakian, M.; Estrade, J.P.; Cravello, L.; Gamerre, M. 2008: Hysteroscopic tubal sterilization (essure) in women with an intrauterine device Journal of Minimally Invasive Gynecology 15(3): 277-279
Kumar, S.; Sethi, R.; Balasubramaniam, S.; Charurat, E.; Lalchandani, K.; Semba, R.; Sood, B. 2014: Women's experience with postpartum intrauterine contraceptive device use in India Reproductive Health 11: 32
Nyklícek, O.; Trávnícek, J. 1974: Local and general reactions of women to intrauterine contraceptive device Casopis Lekaru Ceskych 113(35): 1056-1059
Gottert, A.; Jacquin, K.; Rahaivondrafahitra, B.; Moracco, K.; Maman, S. 2015: Influences on women's decision making about intrauterine device use in Madagascar Contraception 91(4): 289-294